Twitter

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / MOR - Incyte buys global rights for tafasitamab from MorphoSys

MOR - Incyte buys global rights for tafasitamab from MorphoSys

February, 05 2024 05:52 PM MorphoSys AG

2024-02-05 17:52:08 ET

More on Incyte

Incyte: Overly Reliant On Jakafi Despite Positive Phase 2 Results For Axatilimab
Agilent, Incyte to collaborate on companion diagnostics development
Why did Incyte stock go up today? Positive drug study
Seeking Alpha’s Quant Rating on Incyte
Historical earnings data for Incyte

For further details see:

Incyte buys global rights for tafasitamab from MorphoSys

Stock Information

Company Name:	MorphoSys AG
Stock Symbol:	MOR
Market:	NASDAQ
Website:	morphosys.com

MOR MOR Quote MOR Short MOR News MOR Articles MOR Message Board

Get MOR Alerts

News, Short Squeeze, Breakout and More Instantly...

Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.